biology

Inside Wall Street: Where M&A Could Heat Up in Biotech

M&A-watchers see a buyout happening soon in a secluded sector of biotech: DNA sequencing and genetic analysis. One potential buyer is big player Illumina, and one potential buyout target is Wafergen Bio-Systems, whose SmartChip technology is a game-changer.